
Table 5. 1H-NMR of compound (5, 7, 13 and 16)
Table 6. 13C-NMR of compound (5 and 13)
No. Compound structure 1H-NMR spectral data (ᵟppm)
5
7
13
16
2.5 (s, 3H, N-CH3); 2.5 (s, 3H,
); 3.45 (s, 2H, CH2); 3.46 (s,
1H, NH); 3.56 (s, 1H, N-CH
tetrazoline ring); 3.62 (s, 1H, =CH);
4.9 (s, 1H, N-NH-N); 7.6-8.4 (m, 4H,
Ar-H); 9.5 (s, 1H, HN-N)
2.5 (s, 3H, N-CH3); 2.5 (s, 3H,
); 3.58 (s, 2H, CH2); 3.83 (s,
2H, S-CH2); 3.98 (s, 1H, NH); 4.1 (s,
1H, N-CH thiazolidinone ring); 4.2 (s,
1H, =CH); 7.5-8.2 (m, 4H, Ar-H); 8.7
(s, 1H, HN-N)
2.51 (s, 6H, N-(CH3)2); 2.96 (s, 3H, N-
CH3); 2.99 (s, 3H, ); 3.4 (s,
1H, NH); 3.51 (s, 2H, CH2); 3.57 (s,
1H, =CH); 6.75 (s, 1H, N=C-H);
7.63-8.49 (m, 4H, Ar-H); 9.66 (s, 1H,
HN-N)
N
N
O
CH
3
O
CH
3
NH
H
N
N
O
C
H
N
CH
3
CH
3
N
N
O
CH
3
O
CH
3
NH
H
NN
O
H
C
HN
N
N
NO
2
2.5 (s, 3H, N-CH3); 2.5 (s, 3H,
); 3.17 (s, 2H, CH2); 3.17 (s,
2H, CH2-NH); 3.38 (s, 1H, NH); 3.57
(s, 1H, N-CH imidazolidinone ring);
3.59 (s, 2H, N-CH2); 3.67 (s, 1H,
=CH); 7.5-8.3 (m, 4H, Ar-H); 8.7 (s,
1H, HN-N)
No. Compound structure 13C-NMR spectral data (ᵟppm)
5
28.31 (C1, C3); 58.23 (C7); 65.03 (C5);
111.23 (C11); 112.35 (C12
(C10); 152.54 (C6, C9); 160.31 (C2, C4);
165.14 (C8)
13
28.31 (C1, C3); 38.23 (C10); 59.11 (C7);
61.13 (C11); 66.01 (C5); 129.18 (C13);
133.05 (C14); 136.17 (C12
(C15); 152.12 (C6); 160.06 (C2, C4);
166.93 (C8, C9)
N
N
O
H
3
C
O
CH
3
N
H
H
N
O
N
N
CH
3
CH
3
2 6
5
43
1
7
8
9
10
11
12
10
12
11
13
13
N
N
O
O N
H
H
N
O
N
S
Cl
O
2
6
5
43
1
7
8
11
12
9
10
13 14
15
1413
https://doi.org/10.17993/3ctic.2023.121.83-116
3C TIC. Cuadernos de desarrollo aplicados a las TIC. ISSN: 2254-6529
Ed.42 | Iss.12 | N.1 January - March 2023
96